News Home

Should You Buy Burning Rock Biotech Ltd (BNR) in Diagnostics & Research Industry?

Wednesday, May 31, 2023 01:37 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Burning Rock Biotech Ltd (BNR) in Diagnostics & Research Industry?

The 65 rating InvestorsObserver gives to Burning Rock Biotech Ltd (BNR) stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 90 percent of stocks in the Diagnostics & Research industry, BNR’s 65 overall rating means the stock scores better than 65 percent of all stocks.

Overall Score - 65
BNR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on BNR!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Burning Rock Biotech Ltd Stock Today?

Burning Rock Biotech Ltd (BNR) stock is trading at $2.66 as of 12:02 PM on Wednesday, May 31, a loss of -$0.09, or -3.27% from the previous closing price of $2.75. The stock has traded between $2.58 and $2.75 so far today. Volume today is below average. So far 7,317 shares have traded compared to average volume of 32,556 shares. Click Here to get the full Stock Report for Burning Rock Biotech Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App